Kenneth Lynard

Kenneth Lynard is a seasoned executive with extensive experience in finance and strategic leadership across the pharmaceutical and healthcare sectors. Currently serving as Board Member and Group CFO at Zentiva since 2019, Kenneth plays a pivotal role in driving transformation and growth for the pan-European generics and specialty pharmaceutical company. Prior to this, Kenneth was Managing Director and Group CFO at Affidea, overseeing accelerated growth and cost optimization for a leading medical services operator. Kenneth has also held senior positions at Gilead Sciences, where contributions included managing global operations and developing high-performing teams, as well as serving in various finance roles at companies such as Medtronic and Danske Bank. Kenneth holds an Executive MBA from IMD and a Master of Science in Business Economics & Auditing from Copenhagen Business School.